Tailored Adherence Program for Young Adults with Cancer
Trial Summary
What is the purpose of this trial?
A pilot feasibility randomized clinical trial comparing a tailored intervention to uniform standard of care will be conducted. A total of 40 AYAs with cancer will be randomized to one of the two programs. Data will be collected to explore the hypotheses that the intervention meets pre-established enrollment, retention, fidelity, and data completion feasibility criteria and that AYAs will rate the intervention as easy to use and acceptable.
Research Team
Meghan E McGrady, PhD
Principal Investigator
Children's Hospital Medical Center, Cincinnati
Eligibility Criteria
This trial is for adolescents and young adults aged 15-24 with cancer who are prescribed oral chemotherapy or prophylactic medication. They must be fluent in English without significant cognitive deficits, as judged by their medical team, and willing to use an electronic monitoring device. Those already showing high adherence (95% or more) during a preliminary period won't qualify.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Feedback Program
- Tailored Program
Find a Clinic Near You
Who Is Running the Clinical Trial?
Children's Hospital Medical Center, Cincinnati
Lead Sponsor
St. Jude Children's Research Hospital
Collaborator
Seattle Children's Hospital
Collaborator
University of Cincinnati
Collaborator